|Articles|July 1, 2015
Collaborative Success Strategies for Biopharm Companies
Barry Holtz, Principal, at Holtz Biopharma Consulting, and Klyo Collaborative, spoke with BioPharm International about collaborative success strategies for biopharm companies.
Advertisement
Barry Holtz, Principal, at Holtz Biopharma Consulting, and Klyo Collaborative, spoke with BioPharm International about collaborative success strategies for biopharm companies.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
3
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
4
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
5